Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
FDA, Drug Ads
New FDA rules for TV drug ads: Simpler language and no distractions
The new rules, which cover both TV and radio, instruct drugmakers to use simple, consumer-friendly language when describing their drugs, without medical jargon, distracting visuals or audio effects. A 2007 law directed the FDA to ensure that drug risk information appears “in a clear, conspicuous and neutral manner.”
FDA's New Rules Require TV Drug Ads to Be Clearer, More Direct
The new rules become binding on November 20, but many drug companies have already been acting within these requirements. Companies have always been required by the FDA to give a b
FDA implements new rules for drug ads
The U.S. Food and Drug Administration (FDA) has implemented new rules for TV drug ads to make them clearer and more direct in explaining medication risks and side effects.
New FDA rules target those ubiquitous TV drug commercials
The agency’s new guidelines are created to eliminate pharmaceutical company practices that minimize or distract consumers from knowing risk information about drugs.
New FDA rules require TV drug ads to be more clear and direct
The FDA spent more than 15 years crafting the guidelines, which are designed to do away with industry practices that downplay or distract viewers from drug risks.
Why the FDA Wants TV Drug Ads to Use Simpler Words and Lose the Distractions
Clear descriptions of potential risks and side effects will be required under rules that go into effect Nov. 20, even as the Trump administration readies an offensive against big pharma.
FDA puts new restrictions on TV ads for drugs
The new rules instruct drugmakers to use simple, consumer-friendly language when describing their drugs, without medical jargon.
European regulators green light new Alzheimer's drug
European committee takes a second look at Alzheimer’s drug and now says it should be approved
A European regulatory committee now recommends approval of the Alzheimer’s treatment lecanemab a few months after rejecting the drug.
European Watchdog Partially Approves New Alzheimer's Drug
Europe's medicines watchdog on Thursday partially approved a marketing request for a long-awaited new treatment for Alzheimer's disease, reversing an earlier decision not to give it the green light.
European regulators green light new Alzheimer's drug after first rejecting it
European regulators initially said in July that the drug's benefits did not outweigh its risks. View on euronews
14h
on MSN
What happens when you quit Ozempic? How to deal with side effects
Ozempic, a popular weight-loss drug, has helped many shed pounds and improve their health. However, discontinuing the ...
11d
on MSN
Patients Are Suing Over Alleged Side Effects of Weight-Loss Drugs
These drugs are collectively known as GLP-1 agonists because they mimic the body’s natural hormone GLP-1, which regulates ...
GEN
2d
Weight Loss Drug Curbs Appetite, Burns Energy, Skips Side Effects
Researchers believe discovery will springboard research to make more tolerable, effective weight loss treatments accessible ...
WebMD
12d
Biologic Medications (Drugs) and Side Effects
The chances of
side
effects
depend on the type of biologic
drug
you use, how long you use it, your medical history, and how your body responds to the
drug
. One study looked at 1,000 people who ...
2d
Supreme Court dismisses plea to mandate doctors to specify drugs' side effects to patients
Supreme Court dismisses plea mandating doctors to specify drug side effects, citing impracticality and existing regulations.
10d
Zealand’s Weight-Loss Drug Has Minimal Side Effects in Study
Zealand Pharma A/S said moderate doses of its experimental weight-loss drug helped patients pare pounds with less nausea than ...
Medscape
16h
Two Lung Cancer Drugs Recommended by EMA
Two kinase inhibitors have been recommended by the European Medicines Agency for the treatment of non-small cell lung cancer.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback